Insurance Committee February 4, 2026
House Insurance Committee · February 4, 2026
House Insurance Committee heard testimony on House Bill 305, which would cap patient cost sharing for a 30-day supply of insulin at $35; advocates described rationing and health harms, physicians and the American Diabetes Association supported the cap, while a PBM and the Insurance Federation warned it could shift costs to insurers and raise premiums.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No related articles available for this source.
